Showing results (81-90 of 172) with videos related to

Sort By:
Pageof 18
Oncotarget|October 6, 2017
Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogrammingHaymanti Bhanot, Ellen L Weisberg, Mamatha M Reddy, et al.
British Journal of Haematology|January 11, 2005
Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical applicationToshiaki Hayashi, Teru Hideshima, Masaharu Akiyama, et al.
JCO Global Oncology|April 18, 2025
Palliative Radiotherapy Near the End of Life: An Analysis of Factors Influencing the Administration of Radiotherapy in Advanced Tumor DiseaseNguyen-Son Le, Asli Zeybek, Klaus Hackner, et al.
Blood|October 24, 2002
Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341Teru Hideshima, Constantine Mitsiades, Masaharu Akiyama, et al.
The Journal of Biological Chemistry|December 26, 2001
Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activationKlaus Podar, Yu-Tzu Tai, Boris K Lin, et al.
The Journal of Biological Chemistry|March 11, 2004
Critical role for hematopoietic cell kinase (Hck)-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin 6-induced proliferation and survival of multiple myeloma cellsKlaus Podar, Gustavo Mostoslavsky, Martin Sattler, et al.
Blood|January 19, 2006
Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cellsTeru Hideshima, Laurence Catley, Hiroshi Yasui, et al.
Cancer Research|September 17, 2005
A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cellsDharminder Chauhan, Guilan Li, Klaus Podar, et al.
Frontiers in Oncology|August 28, 2020
Reduced LDL-Cholesterol and Reduced Total Cholesterol as Potential Indicators of Early Cancer in Male Treatment-Naïve Cancer Patients With Pre-cachexia and CachexiaHannes Zwickl, Klaus Hackner, Harald Köfeler, et al.
Clinical Breast Cancer|July 2, 2017
Single-Agent Oral Vinorelbine as First-Line Chemotherapy for Endocrine-Pretreated Breast Cancer With Bone Metastases and No Visceral Involvement: NORBREAST-228 Phase II StudyGuenther G Steger, Adriana Dominguez, Natalia Dobrovolskaya, et al.
Pageof 18